Osteodystrophy in liver cirrhosis: detection and treatment evaluation using 99Tcm methylene diphosphonate bone scintigraphy.
To investigate osteodystrophy in liver cirrhosis, 99Tcm MDP (methylene diphosphonate) bone scintigraphy was performed on 36 patients with liver cirrhosis. Abnormal lesions were detected in 17 out of 36 scans (47.2%). On the other hand, areas of increased uptake were uncommon in patients with chronic active hepatitis (1/11 cases). Plasma vitamin D3 fractions [25(OH)D3, 24.25(OH)2D3 and 1.25(OH)2D3] were decreased. Statistically significant depletion of 1.25(OH)2D3 was observed in cases with positive bone scintigraphy. 1 alpha(OH)D3 (1-2 micrograms/day) was administered for 6 months to nine patients having abnormal bone scans. Six of them showed improvement without any apparent side-effects. We conclude that hepatic cirrhotic osteodystrophy can be diagnosed positively by 99Tcm MDP bone scintigraphy and can be treated accordingly.
Sezai
S
S
Division of Gastroenterology, Tokyo Metropolitan Police Hospital, Japan.
Hirano
M
M
Iwase
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000209:etiology; D002762:Cholecalciferol / Q000097:blood; D005069:Evaluation Studies as Topic; D005260:Female; D006521:Hepatitis, Chronic / Q000000981:diagnostic imaging; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D012272:Ribs / Q000000981:diagnostic imaging; D013131:Spine / Q000000981:diagnostic imaging; D013669:Technetium Tc 99m Medronate
D006887:Hydroxycholecalciferols; D002762:Cholecalciferol; C008088:alfacalcidol; D013669:Technetium Tc 99m Medronate